The shares of ChemoCentryx, Inc. (NASDAQ:CCXI) started off the last trading session with the price of $12.05 while closing the day with the price of $12.19. The shares of ChemoCentryx, Inc. (NASDAQ:CCXI) Rise 0% with the Gain of 0.14 points.
The shares of ChemoCentryx, Inc. (NASDAQ:CCXI) traded with the day volume of 872144 shares whereas its average trading volume is 235.23 Million.
While analyzing the past performance of the stock we can see that the shares of ChemoCentryx, Inc. (NASDAQ:CCXI) Gain 12.25% in the last week while rising 31.93% in the last month. Past quarter performance shows the green light with 105.91%. The semi-annual and annual performance shows 66.53% and 82.76% respectively.
Some critical values of the shares of ChemoCentryx, Inc. (NASDAQ:CCXI) to be discussed here are: the beta which shows the value at 1.91 while Average True Range of ChemoCentryx, Inc. (NASDAQ:CCXI) demonstrate the value at 0.8. The weekly and monthly volatility of the shares of ChemoCentryx, Inc. (NASDAQ:CCXI) are indicated at 6.28% and 7.96%. Also to discuss here is the Relative Strength Index or RSI which is depicted at 76.21.
While studying the financial position of the shares of ChemoCentryx, Inc. (NASDAQ:CCXI), we can see that the Market capitalization of the company is at 531.12 Million. The shares outstanding for the company is 43.57 Million and the shares float stands at 28.87 Million. The income of the company stand at -29500000 while the sales stand at 31.1 Million.
Here are some critical ratios for a financial perspective: Earnings Per Share or EPS of the company stand at -0.61, Price to Earnings or P/E is at 0, Price to Sales P/S show the value of 17.08, the Return on Asset ROA stood at -0.208 and the Return on Equity ROE depicted at -0.687 while Return on Investment ROI is at 0.
Momenta Pharmaceuticals Inc. (NASDAQ:MNTA)
Momenta Pharmaceuticals Inc. (NASDAQ:MNTA) started its previous trading session at $18.55 and closed at $18.7 showing a Rise of 1.08 Percent.
The Company traded with an average Volume of 883.2 Million whereas, its Day Volume stood at 760907.
Looking at the performance of the stock, Momenta Pharmaceuticals Inc. (NASDAQ:MNTA) Gain 6.25% in the last week in its shares price and 17.61% in the last month. Quarterly performance shows a green of 50.81 Percent while Semi-Annual and Annual performances shows a 10.32 and 32.16 percent respectively.
Beta for Momenta Pharmaceuticals Inc. (NASDAQ:MNTA) stands at 1.72 while the ATR (average true range) is at 0.82. The Stock’s Weekly and Monthly Volatility is 3.81% and 5.10% respectively showing a RSI value of 72.47.
While studying the financial position of the shares of Momenta Pharmaceuticals Inc. (NASDAQ:MNTA), we can see that the Market capitalization of the company is at 1.36 Billion. The shares outstanding for the company is 72.91 Million and the shares float stands at 71.76 Million.
The Company generated an income of -88100000 and the sales of 138.9 Million in the Trailing Twelve Months period.
While analyzing the stock from technical aspects, Diluted Earnings per share stands at $-1.22 a share. P/E (price to earnings) and P/S (price to sales) values are 0 and 9.82 respectively.
The Return on Assets stands at -0.174, ROE shows a value of -0.236 and ROI for Momenta Pharmaceuticals Inc. (NASDAQ:MNTA) is -0.247 as of Trailing Twelve Months period.
